MAIA Biotechnology (MAIA) Non-Current Assets (2021 - 2026)
MAIA Biotechnology (MAIA) recorded Non-Current Assets of $2,800 in Q2 2026, unchanged from $2,800 a year earlier and down 62.8% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Non-Current Assets (2021 - 2026) Analysis & Trends
Starting with Q4 2021, MAIA Biotechnology's Non-Current Assets history includes 18 quarters.
- Annual Non-Current Assets has a four-year compound annual growth rate of -74.4% (FY2021 to FY2025).
- Across earlier years, Non-Current Assets came in at $2,800 in FY2024 (unchanged), $2,800 in FY2023 (-98.7%), $214,003 in FY2022 (-67.3%) and $654,704 in FY2021.
- Quarterly Non-Current Assets has ranged from $2,800 in Q3 2022 to $1.15 million in Q2 2022 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in two of the last eight quarters, with growth averaging 106.8%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 867.3% in Q3 2025, against a decline of 99.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $7,518 (Q1 2026), $2,800 (Q4 2025) and $27,085 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | MAIA Biotechnology | 65.45 Mn | -26.56 Mn | - | 2,800.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2,800.00 |
| Jun 30, 2026 | 2,800.00 |
| Mar 31, 2026 | 7,518.00 |
| Dec 31, 2025 | 2,800.00 |
| Sep 30, 2025 | 27,085.00 |
| Jun 30, 2025 | 2,800.00 |
| Mar 31, 2025 | 2,800.00 |
| Dec 31, 2024 | 2,800.00 |
| Sep 30, 2024 | 2,800.00 |
| Jun 30, 2024 | 2,800.00 |
| Mar 31, 2024 | 16,035.00 |
| Dec 31, 2023 | 2,800.00 |
| Sep 30, 2023 | 367,940.00 |
| Jun 30, 2023 | 492,449.00 |
| Mar 31, 2023 | 740,488.00 |
| Dec 31, 2022 | 214,003.00 |
| Sep 30, 2022 | 2,800.00 |
| Jun 30, 2022 | 1.15 Mn |
| Dec 31, 2021 | 654,704.00 |
API Access
MAIA Biotechnology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();